SIRT3 can relieve myocardial damage post-MI by inhibiting mitochondrial fission [11], whereas overexpression of SIRT3 can delay the progression of heart failure (HF) by improving mitochondrial biological function [12]. The gene discussed is SIRT3; the disease is hydrops fetalis.